Event Protocol's Biomarkers in Diagnostics & Therapeutics will serve to scrutinize the promises of biomarker research upon integration into new drug discovery and development, enabling informed clinical trials with improved design to increase pace to market. In addition, the co-development of biomarkers assay development and molecular diagnostics will inevitably strengthen the field of companion diagnostics and catapult healthcare in the direction of personalized medicine.
Explore
